Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -7.30 | -8.05 | -6.64 | 26.17% | CHEMBL82488 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -8.84 | -6.25 | N/A | 41.55% | CHEMBL3676849 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.53 | -8.64 | -8.88 | 33.88% | CHEMBL1909065 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.18 | -8.54 | N/A | 33.88% | CHEMBL1909065 |
AA1R_HUMAN | adenosine A1 receptor | -7.91 | -8.37 | -3.53 | 23.16% | CHEMBL162752 |
AA2AR_HUMAN | adenosine A2a receptor | -5.99 | -6.46 | -5.40 | 22.22% | CHEMBL2381770 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.31 | -8.63 | -7.97 | 37.33% | CHEMBL4633410 |
ACE_HUMAN | angiotensin I converting enzyme | -8.31 | -8.50 | -6.04 | 27.33% | CHEMBL284898 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.83 | N/A | N/A | 13.66% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | 4.58 | 0.10 | -4.92 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -6.30 | 10.80 | N/A | 35.42% | CHEMBL75217 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -8.02 | -5.84 | N/A | 34.92% | CHEMBL285440 |
ADRB2_HUMAN | adrenoceptor beta 2 | -6.94 | -6.04 | -8.77 | 33.73% | CHEMBL1431082 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -7.69 | -7.88 | -7.58 | 18.37% | CHEMBL214592 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.37 | -7.74 | -7.33 | 29.45% | CHEMBL284616 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.87 | -9.13 | -8.82 | 22.86% | CHEMBL1821978 |
AOFA_HUMAN | monoamine oxidase A | -7.65 | -7.49 | -0.91 | 31.82% | CHEMBL488917 |
AOFB_HUMAN | monoamine oxidase B | -7.32 | -2.86 | -4.11 | 33.33% | CHEMBL1830818 |
BACE1_HUMAN | beta-secretase 1 | -7.04 | -8.23 | -8.47 | 33.08% | CHEMBL3586204 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.51 | -7.99 | -8.15 | 33.85% | CHEMBL3137782 |
CASP1_HUMAN | caspase 1 | -6.04 | -6.73 | -6.61 | 36.42% | CHEMBL1222905 |
CDK5_HUMAN | cyclin dependent kinase 5 | -6.49 | -5.55 | -5.38 | 21.63% | CHEMBL422897 |
CHLE_HUMAN | butyrylcholinesterase | -9.12 | -8.62 | -8.79 | 28.57% | CHEMBL3586200 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.76 | -5.96 | -6.50 | 30.77% | CHEMBL233637 |
CNR2_HUMAN | cannabinoid receptor 2 | -5.65 | -9.58 | N/A | 30.77% | CHEMBL233637 |
COLI_HUMAN | proopiomelanocortin | -7.15 | -7.45 | -5.96 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -5.69 | -5.95 | -5.39 | 21.68% | CHEMBL1091981 |
CRP_HUMAN | C-reactive protein | -5.91 | -5.65 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -0.28 | N/A | N/A | 24.18% | CHEMBL246733 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -7.83 | -7.09 | -7.76 | 21.07% | CHEMBL1221944 |
DRD2_HUMAN | dopamine receptor D2 | -7.13 | N/A | N/A | 41.55% | CHEMBL3676849 |
DRD3_HUMAN | dopamine receptor D3 | -7.85 | N/A | N/A | 41.55% | CHEMBL3676849 |
DRD4_HUMAN | dopamine receptor D4 | -8.05 | -8.44 | N/A | 31.01% | CHEMBL3318841 |
EDN1_HUMAN | endothelin 1 | -7.29 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -5.05 | -5.12 | -4.99 | 39.11% | CHEMBL486386 |
FABP5_HUMAN | fatty acid binding protein 5 | -8.88 | -6.71 | -6.17 | 38.66% | CHEMBL4288603 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -7.21 | N/A | N/A | 29.07% | CHEMBL506247 |
GLRA3_HUMAN | glycine receptor alpha 3 | -7.75 | -7.61 | -7.77 | 14.64% | CHEMBL4074873 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.86 | N/A | N/A | 14.64% | CHEMBL4074873 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | 0.70 | 0.01 | -0.09 | 23.03% | CHEMBL92162 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -5.55 | -6.94 | -6.10 | 17.68% | CHEMBL4463046 |
HRH1_HUMAN | histamine receptor H1 | 2.57 | N/A | N/A | 25.74% | CHEMBL1201203 |
HYES_HUMAN | epoxide hydrolase 2 | -8.52 | -8.01 | -8.61 | 34.06% | CHEMBL4207574 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -7.25 | N/A | N/A | 28.93% | CHEMBL3318173 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -7.94 | -7.58 | N/A | 51.61% | CHEMBL1829519 |
MIF_HUMAN | macrophage migration inhibitory factor | -5.32 | -5.63 | -5.61 | 25.88% | CHEMBL211882 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -6.82 | -6.84 | -7.62 | 29.07% | CHEMBL506247 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -6.06 | -6.66 | -6.58 | 26.21% | CHEMBL1934583 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.48 | -8.46 | -8.95 | 36.10% | CHEMBL428496 |
NEP_HUMAN | membrane metalloendopeptidase | -8.21 | -7.68 | -7.47 | 30.95% | CHEMBL4070297 |
NK1R_HUMAN | tachykinin receptor 1 | -8.05 | -6.88 | -6.75 | 40.60% | CHEMBL378984 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.66 | -7.86 | -6.86 | 10.99% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.35 | -6.75 | -6.02 | 31.82% | CHEMBL4169479 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.81 | -7.87 | -6.86 | 17.49% | CHEMBL325890 |
NOS1_HUMAN | nitric oxide synthase 1 | -7.22 | -7.25 | -7.48 | 18.18% | CHEMBL4530822 |
NOS2_HUMAN | nitric oxide synthase 2 | -5.88 | -7.47 | -4.00 | 21.43% | CHEMBL1037 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -7.80 | -7.52 | -8.19 | 22.13% | CHEMBL444109 |
OPRD_HUMAN | opioid receptor delta 1 | -7.14 | -6.66 | -7.18 | 73.23% | CHEMBL3330670 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.75 | -8.01 | -8.12 | 100.00% | CHEMBL272939 |
OPRM_MOUSE | Mu-type opioid receptor | -7.97 | -8.29 | N/A | 27.72% | CHEMBL2205421 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.64 | -6.62 | -7.36 | 32.50% | CHEMBL3581762 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -6.32 | -6.02 | -5.76 | 25.48% | CHEMBL3669841 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -7.03 | -1.22 | -6.62 | 26.97% | CHEMBL420980 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -6.13 | N/A | N/A | 30.37% | CHEMBL2012510 |
PDE4B_HUMAN | phosphodiesterase 4B | -7.22 | -8.16 | -7.93 | 28.21% | CHEMBL2063002 |
PDE5A_HUMAN | phosphodiesterase 5A | -6.67 | -7.41 | -7.49 | 25.31% | CHEMBL497293 |
PERM_HUMAN | myeloperoxidase | -8.03 | -7.96 | -7.91 | 23.13% | CHEMBL278555 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -2.76 | -4.14 | -2.59 | 33.81% | CHEMBL447689 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | 5.13 | 2.52 | -6.30 | 38.06% | CHEMBL516139 |
PPAP_HUMAN | acid phosphatase 3 | -8.23 | -8.07 | N/A | 9.70% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -7.50 | -6.26 | -7.48 | 40.34% | CHEMBL3337640 |
PRGR_HUMAN | progesterone receptor | -6.98 | -5.00 | -8.69 | 31.44% | CHEMBL1676 |
PTGES_HUMAN | prostaglandin E synthase | -5.76 | N/A | N/A | 27.35% | CHEMBL3289107 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -8.79 | -8.80 | -8.28 | 38.46% | CHEMBL2012104 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.13 | N/A | N/A | 32.06% | CHEMBL381488 |
TLR4_HUMAN | toll like receptor 4 | -7.01 | -6.60 | -6.74 | 31.76% | CHEMBL1910027 |
TNFA_HUMAN | tumor necrosis factor | -7.68 | -7.35 | -5.76 | 27.57% | CHEMBL3983488 |
TRBM_HUMAN | thrombomodulin | -6.67 | -6.79 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.90 | -6.31 | N/A | 15.03% | CHEMBL1408302 |
TRPM8_FICAL | Uncharacterized protein | -9.44 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.15 | N/A | N/A | 33.51% | CHEMBL99940 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.12 | -6.94 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.20 | -5.96 | N/A | 19.17% | CHEMBL3664218 |
TRXR1_HUMAN | thioredoxin reductase 1 | -9.31 | -7.80 | -6.66 | 15.95% | CHEMBL4281382 |
TRY1_HUMAN | serine protease 1 | -5.68 | N/A | N/A | 38.05% | CHEMBL101030 |